In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
Steven Mento, PhD, Co-Founder, President & CEO, Conatus Pharmaceuticals, introduces Conatus’s latest project, Emricasan, a therapy for acute catastrophic liver disease. With 2 billion people worldwide with liver…
With the disastrous launch of the HealthCare.gov website, critics of the Affordable Care Act, or “Obamacare,” were given more fuel for the fire. Is this political hot potato’s…
When a new drug is approved by the U.S. Food and Drug Administration, it is assume to be safe and effective. But are all drug approvals created equal?…
Calcium plaque in the arteries of the heart is a sign of changes that can lead to heart attacks. To measure this calcium physicians sometimes use a form…
For many elderly patients, including those with diabetes and peripheral neuropathy, falls are the leading cause of death. The Journal of the American Podiatric Association discusses podatrist’s role in…
Rallie McAllister, MD, MPH, CBR Spokesperson and Co-author of The Mommy MD Guides, discusses the limitless possibilities offered by cord blood banking. Regenerative medicine, in particular, is a…
The New Year often brings resolutions, including quitting smoking. Fifty years ago this month, the Surgeon General released the first report on smoking and health in the United…
Vitamin E and the drug memantine have been shown to slow progression of moderate to severe Alzheimer’s disease. A new study looked at whether or not these two…
NEW YORK (Reuters Health) – The extent of resection and residual volume are independently tied to survival and recurrence after surgery for newly diagnosed glioblastoma, according to a…
By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
